Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Greece

Innovation Action · Running

UniHealth Development of a global diagnostic ecosystem for detecting and monitoring emergency-prone pathogens across species and in a unified way

Coordinator
Idryma Technologias Kai Erevnas, Greece
Runs
1 December 2023 to 31 May 2027
Status
Running
EU funding
€4.9m
Total cost
€5.3m
Partners
11 organisations in 8 countries
Type
Innovation Action
Grant agreement
101137092

What the project is doing

In the project's own words, from its summary on CORDIS.

We aim to contribute to global diagnostics and preparedness for the next health crisis by developing in vitro diagnostic devices and methodologies for application at the point-of-care. For this purpose, mature as well as novel technologies and assays will be developed, addressing all pandemic preparedness requirements; i.e., with regards to assay characteristics and ability to assimilate new targets as well as platform ease of use and connectivity fulfilling manufacturing and regulatory requirements.

In the 36 months of the project, we intend to develop and deliver two IVDR certified devices and six molecular assays for emerging pathogens detection at the point-of-care. We will build on a recent commercial success during the COVID-19 pandemic, the Pebble platform and an innovative pocket-size device to be developed within the project, both providing capability for connectivity and surveillance. For the RNA-targets detection, we will employ a recently developed amplification method (DAMP) demonstrated to have a high specificity in crude samples.

Three broad assays will be developed for screening of viruses belonging in one of the families of Corona, Influenza or Arboviruses, and three specific ones for Dengue, Zika and West Nile viruses, all according to IVDR-recommendations. Importantly the above six assays will be tested using samples from humans, animals and during field-monitoring of mosquito populations, providing a solution for the One Health initiative.

For the development of accessible diagnostic tools, the UniHealth consortium consist of expert researchers, technologists, doctors, social scientists, regulators, innovators and biomedical device providers within the areas of diagnostics and pandemics. The high degree of UniHealth’s innovation and the co-development of solutions with global partners and end-users will expand the visibly and uptake of the project results to a global level leading to a high preparedness and an economic and social success.

Who is involved

OrganisationCityCountryRole
Idryma Technologias Kai ErevnasIrakleioGreeceCoordinator
Pknm Solutions SARLColombierSwitzerlandAssociatedpartner
Charite - Universitaetsmedizin BerlinBerlinGermanyParticipant
Biopix Dna Technology Anonymi EtairiaHeraklionGreeceParticipant
Elliniki Enosi Biotechnologias Astiki Mi Kerdoskopiki EtairiaAthensGreeceParticipant
Institut PasteurParisFranceParticipant
Haraldsplass Diakonale Sykehus ASBergenNorwayParticipant
Universitetet I BergenBergenNorwayParticipant
Institut Pasteur De TunisTunisTunisiaParticipant
University College London Hospitalsnhs Foundation TrustLondonUnited KingdomAssociatedpartner
Kiara Health (pty) LtdRandjesfonteinSouth AfricaParticipant

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI